Now, simple jab could bring relief to millions of arthritis sufferers

Image
ANI Washington
Last Updated : Feb 27 2014 | 11:15 AM IST

A powerful injection delivered directly into arthritic joints could cut pain levels for millions of sufferers.

Scientists have found a way to stop nerve cells in diseased joints sensing pain - without any side effects, the Daily Express reported.

They say their discovery could drastically cut the number of knee and hip replacements performed in Britain each year - currently around 160,000, and costing the NHS almost 200 million pounds.

Scientists from the Arthritis Research UK Pain Centre at Nottingham University targeted a nerve cell pain receptor called TRPV1.

Previous trials on osteoarthritis patients showed their pain could be cut by blocking the receptor using drugs called TRPV1 antagonists. But the patients experienced the side effect of hyper-thermia - overheating of the body - apparently in their digestive organs.

Neuroscience lecturer Dr Sara Kelly explained that the Nottingham team used a model of osteoarthritis pain to see if using the drugs within the joint itself would work better.

Dr Kelly said that by targeting the joint directly they did not see the side effect of hyperthermia.

The study is published in the journal Annals Of The Rheumatic Diseases.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 27 2014 | 11:03 AM IST

Next Story